Literature DB >> 3840555

[Indications for conservative and operative therapy of thyroid autonomy and Basedow hyperthyroidism from the internal medicine viewpoint].

C R Pickardt.   

Abstract

The risk of recurrent hyperthyroidism can be eliminated indefinitely in patients with autonomously functioning thyroid tissue (AFTT) by selective surgery or radioiodine, whereas medical treatment inhibits only the actual thyroid hormone over-production. Therefore, AFTT should be removed. In immunogenic hyperthyroidism the natural history of the disease can be influenced only symptomatically. The relapse rate after medical treatment is more than 50%. After surgical or radioactive therapy long-term remission of hyperthyroidism, not of the underlying thyroid disease can be achieved more effectively. Therefore surgical treatment should be preferred.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840555     DOI: 10.1007/bf01836604

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  4 in total

1.  [Therapy of hyperthyroidism. Results of the meeting of the section Thyroid Gland of the Deutsche Gesellschaft für Endokrinologie December 2 and 3 1976, in Göttingen].

Authors:  D Emrich; V Bay; P Freyschmidt; K Hackenberg; J Herrmann; A Mühlen; C R Pickardt; C Schneider; P C Scriba; P Stubbe
Journal:  Dtsch Med Wochenschr       Date:  1977-09-02       Impact factor: 0.628

2.  Indication for operation of patients with autonomously functioning thyroid tissue in endemic goiter areas.

Authors:  P E Goretzki; R A Wahl; D Branscheid; K Joseph; A Tsuchiya; H D Röher
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

3.  [Thyroid function following radioiodine resection of autonomous thyroid adenomas].

Authors:  H G Heinze; C R Pickardt; G Swoboda; K Horn; F Erhardt; P C Scriba
Journal:  Nuklearmedizin       Date:  1977-10       Impact factor: 1.379

4.  Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.

Authors:  M A Greer; H Kammer; D J Bouma
Journal:  N Engl J Med       Date:  1977-07-28       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.